Email: cspc@cspc.cn
News
December 04, 2024
Share:
Previous: ACCEPTANCE OF APPLICATION FOR MARKETING APPROVAL OF SYHX2011 FOR THE TREATMENT OF ADVANCED BREAST CANCER
Next: ACCEPTANCE OF BIOLOGIC LICENSE APPLICATION OF USTEKINUMAB INJECTION
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us